Author

A. Bezault

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:cryo-EM· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:simulation· 1 Research Focus:software / tool· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

B. Rodriguez de Francisco· 2 shared D. Hanein· 2 shared N. Volkmann· 2 shared C. Sauvanet· 1 shared J. M. Nicholls· 1 shared K. P. Hui· 1 shared K.-c. Ng· 1 shared M. C. Chan· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

B. Rodriguez de Francisco

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MEPSi: A tool for simulating tomograms of membrane-embedded proteins

B. Rodriguez de Francisco, A. Bezault, X.-P. Xu, D. Hanein, N. Volkmann

MEPSi simulates tomograms of membrane-embedded proteins to evaluate and optimize cryo-ET data acquisition parameters before experimental imaging.

bioRxiv · Jul 27, 2022 · PreprintCell Biology

Novel ACE2 nanoparticles universally block SARS-CoV-2 variants in the human respiratory tract

C. Sauvanet, M. Lemos, A. Bezault, B. Rodriguez de Francisco, M. C. Chan, K. P. Hui, K.-c. Ng, J. M. Nicholls, N. Volkmann, D. Hanein

This study develops hACE2 nanoparticles that block SARS-CoV-2 and its variants by sequestering viruses through aggregation in cell systems and human respiratory tract explants.

bioRxiv · May 5, 2022 · PreprintCell Biology